Publication|Articles|July 21, 2026
Supplements and Featured Publications
- Considerations for the Management of Overactive Bladder in Long-Term Care
Considerations for the Management of Overactive Bladder in Long-Term Care
This clinical brief is supported by Sumitomo Pharma America.
Advertisement
This information is intended solely for payer and formulary decision makers and is provided for informational purposes regarding reimbursement and healthcare decision-making. This material is non-promotional and should not be distributed or used for promotional purposes.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Prior Cancer History Predicts Second Cancers in Polycythemia Vera, Essential Thrombocythemia
2
CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks
3
Medicaid MFN Pricing Could Save $8.6 Billion
4
Active US Drug Shortages Rise for Third Straight Quarter
5